LT - PHARMACEUTICALLY ACCEPTABLE SALT OF (E)-N-[4-[[3-CHLORO-4-(2-PYRIDYLMETHOXY)PHENYL]AMINO]-3-CYANO-7-ETHOXY-6-QUINOLYL]-3-[(2R)-1-METHYLPYRROLIDIN-2-YL]PROP-2-ENAMIDE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF
EN - PHARMACEUTICALLY ACCEPTABLE SALT OF (E)-N-[4-[[3-CHLORO-4-(2-PYRIDYLMETHOXY)PHENYL]AMINO]-3-CYANO-7-ETHOXY-6-QUINOLYL]-3-[(2R)-1-METHYLPYRROLIDIN-2-YL]PROP-2-ENAMIDE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
| (51) |
INT.CL. |
C07D 401/14 |
|
|
|
A61K 31/4709 |
|
|
|
A61P 35/00 |
|
Europos patentas
| (11) |
Patento numeris |
2684877 |
| (13) |
Dokumento rūšis |
T |
| (96) |
Europos patento paraiškos numeris |
12757831.8 |
|
Europos patento paraiškos padavimo data |
2012-02-10 |
| (97) |
Europos patento paraiškos paskelbimo data |
2014-01-15 |
| (45) |
Paskelbimo apie Europos patento išdavimą data |
2016-10-19
|
| (46) |
Apibrėžties vertimo paskelbimo data |
|
Tarptautinės paraiškos padavimo
| (86) |
Numeris |
PCT/CN2012/071015 |
|
Data |
2012-02-10 |
Tarptautinės paraiškos paskelbimo
| (87) |
Numeris |
WO 2012/122865 |
|
Data |
2012-09-20 |
Prioriteto paraiškos
| (30) |
Numeris |
Data |
Šalis |
|
201110062359 |
2011-03-11
|
CN |
Išradėjai
| (72) |
LI, Xin, CN
WANG, Bin, CN
|
Savininkas
| (73) |
Shanghai Hengrui Pharmaceutical Co. Ltd.,
279 Wenjing Road, Minhang District Shanghai 200245,
CN
Jiangsu Hengrui Medicine Co. Ltd.,
No. 7 Kunlunshan Road Economic and Technological Development Zone Lianyungang, Jiangsu 222047,
CN
|
Pavadinimas
| (54) |
PHARMACEUTICALLY ACCEPTABLE SALT OF (E)-N-[4-[[3-CHLORO-4-(2-PYRIDYLMETHOXY)PHENYL]AMINO]-3-CYANO-7-ETHOXY-6-QUINOLYL]-3-[(2R)-1-METHYLPYRROLIDIN-2-YL]PROP-2-ENAMIDE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF |
| |
PHARMACEUTICALLY ACCEPTABLE SALT OF (E)-N-[4-[[3-CHLORO-4-(2-PYRIDYLMETHOXY)PHENYL]AMINO]-3-CYANO-7-ETHOXY-6-QUINOLYL]-3-[(2R)-1-METHYLPYRROLIDIN-2-YL]PROP-2-ENAMIDE, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF |
